RxDoctor Payments DataLook up a doctor →

William Eaves, MD

Cardiovascular Disease · Shreveport, LANPI 1801861240

Payments from drug & device makers

$1,618,961in general payments, 2019–2025

Across 1,386 payments — averaging $1168.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$399K
  • Boehringer Ingelheim$333K
  • Amgen$185K
  • Janssen Research & Development, LLC$108K
  • Boehringer Ingelheim International GmbH$96K
  • Pfizer$74K
  • plus $424K from 54 others
$38,724in research payments, 2019–2025

Across 9 payments — averaging $4302.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$25K
  • Philips North America LLC$14K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis69$398,789
Boehringer Ingelheim31$333,412
Amgen20$184,860
Janssen Research & Development, LLC24$107,644
Boehringer Ingelheim International GmbH227$96,248
Pfizer80$74,227
Novo Nordisk AS327$65,376
AstraZeneca25$63,169
Eli Lilly8$59,982
Boehringer Ingelheim Pharma GmbH & Co.kg13$54,439
Boston Scientific126$45,861
Alnylam Pharmaceuticals Inc.51$34,217
Surmodics, Inc.56$31,536
Bard Peripheral Vascular, Inc.6$16,500
Ionis Pharmaceuticals, Inc.8$14,570
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)48$10,527
M.a. Med Alliance S.A.3$9,534
Bayer11$6,167
Philips North America LLC37$4,334
E.r. Squibb & Sons, L.L.C.10$1,877
Abiomed28$759
Shockwave Medical, Inc21$688
Itamar Medical Inc5$614
Abbott16$484
Inari Medical, Inc.18$432
Merck17$283
Kestra Medical Technology Services, Inc.9$281
Sanofi-aventis U.S. LLC18$242
Stryker10$238
Cardiva Medical, Inc.6$211
Irhythm Technologies, Inc.3$188
Medtronic(2 entities)10$166
W. L. Gore & Associates, Inc.5$131
Endologix LLC1$107
Avantec Vascular Corporation1$91
Atricure, Inc.1$67
Regeneron Healthcare Solutions, Inc.5$65
Boehringer Ingelheim France S.a.s.2$58
Avinger Inc.1$53
Novo Nordisk3$51
Johnson & Johnson3$42
Inspire Medical Systems, Inc.1$40
Terumo Medical Corporation2$40
Celonova Biosciences, Inc.1$37
Recor Medical Inc2$36
Elutia, Inc.2$33
Actelion Pharmaceuticals US, Inc.2$29
Biotronik Inc.1$24
Kiniksa Pharmaceuticals International, PLC1$23
Reflow Medical Inc1$23
Bardy Diagnostics, Inc.1$21
Lexicon Pharmaceuticals, Inc.1$19
ZOLL Circulation Inc1$18
Angiodynamics, Inc.1$16
Daiichi Sankyo Inc.1$15
Esperion Therapeutics, Inc.1$15
Argon Medical Devices, Inc.1$13
Baxter Healthcare1$13
GE HealthCare1$13
Teleflex LLC1$12

How this compares

$1,618,961 in reported general payments places this provider in the 95th percentile of 281 cardiovascular disease providers in Louisiana.

See all cardiovascular disease providers in Louisiana →

Medicare billing

Part B allowed, 2024
$423,686
Medicare patients
935
Services billed
3,561

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Shreveport

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →